Change Path LLC bought a new position in shares of UnitedHealth Group Inc (NYSE:UNH) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,920 shares of the healthcare conglomerate’s stock, valued at approximately $478,000.

Several other institutional investors have also recently bought and sold shares of the company. CI Investments Inc. grew its holdings in UnitedHealth Group by 5.8% during the third quarter. CI Investments Inc. now owns 949,719 shares of the healthcare conglomerate’s stock worth $252,663,000 after acquiring an additional 52,023 shares during the period. Martingale Asset Management L P grew its holdings in UnitedHealth Group by 1.7% during the third quarter. Martingale Asset Management L P now owns 214,133 shares of the healthcare conglomerate’s stock worth $56,969,000 after acquiring an additional 3,598 shares during the period. Blue Fin Capital Inc. grew its holdings in UnitedHealth Group by 7.2% during the third quarter. Blue Fin Capital Inc. now owns 10,689 shares of the healthcare conglomerate’s stock worth $2,844,000 after acquiring an additional 722 shares during the period. Veritable L.P. grew its holdings in UnitedHealth Group by 1.7% during the third quarter. Veritable L.P. now owns 40,629 shares of the healthcare conglomerate’s stock worth $10,809,000 after acquiring an additional 695 shares during the period. Finally, Bluefin Trading LLC acquired a new position in UnitedHealth Group during the third quarter worth about $578,000. Institutional investors own 86.68% of the company’s stock.

A number of research analysts recently issued reports on the company. Morgan Stanley lowered their target price on UnitedHealth Group from $315.00 to $285.00 and set an “overweight” rating on the stock in a report on Wednesday. Barclays lowered their target price on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a report on Wednesday. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $258.00 target price on the stock in a report on Wednesday. Citigroup lowered their target price on UnitedHealth Group from $288.00 to $247.00 and set a “neutral” rating on the stock in a report on Wednesday. Finally, SunTrust Banks lowered their target price on UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a report on Wednesday. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, one has assigned a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $291.56.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total value of $1,333,050.00. Following the transaction, the director now owns 77,702 shares of the company’s stock, valued at approximately $20,716,130.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 2,930 shares of UnitedHealth Group stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the completion of the transaction, the director now directly owns 64,726 shares in the company, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. Insiders sold a total of 17,930 shares of company stock worth $4,587,133 in the last three months. 0.87% of the stock is currently owned by company insiders.

Shares of UNH opened at $221.75 on Friday. The stock has a market capitalization of $212.78 billion, a P/E ratio of 17.22, a P/E/G ratio of 1.18 and a beta of 0.79. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $287.94. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.73 and a current ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion for the quarter, compared to analysts’ expectations of $59.72 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. UnitedHealth Group’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the business posted $3.04 EPS. As a group, equities analysts forecast that UnitedHealth Group Inc will post 14.63 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://theolympiareport.com/2019/04/20/1920-shares-in-unitedhealth-group-inc-unh-purchased-by-change-path-llc.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What are the advantages of the Stochastic Momentum Index?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.